- Home
- MGM vs ROIV Comparison
MGM vs ROIV Comparison
Compare MGM & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGM
- ROIV
- Stock Information
- Founded
- MGM 1986
- ROIV 2014
- Country
- MGM United States
- ROIV United Kingdom
- Employees
- MGM N/A
- ROIV N/A
- Industry
- MGM Hotels/Resorts
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- MGM Consumer Discretionary
- ROIV Health Care
- Exchange
- MGM Nasdaq
- ROIV Nasdaq
- Market Cap
- MGM 9.9B
- ROIV 8.4B
- IPO Year
- MGM N/A
- ROIV N/A
- Fundamental
- Price
- MGM $32.83
- ROIV $11.15
- Analyst Decision
- MGM Strong Buy
- ROIV Strong Buy
- Analyst Count
- MGM 15
- ROIV 8
- Target Price
- MGM $52.27
- ROIV $17.93
- AVG Volume (30 Days)
- MGM 4.4M
- ROIV 5.3M
- Earning Date
- MGM 02-12-2025
- ROIV 02-11-2025
- Dividend Yield
- MGM N/A
- ROIV N/A
- EPS Growth
- MGM N/A
- ROIV N/A
- EPS
- MGM 2.82
- ROIV 5.89
- Revenue
- MGM $17,221,656,000.00
- ROIV $129,128,999.00
- Revenue This Year
- MGM $7.73
- ROIV $15.98
- Revenue Next Year
- MGM $0.14
- ROIV N/A
- P/E Ratio
- MGM $11.67
- ROIV $1.98
- Revenue Growth
- MGM 12.31
- ROIV 145.68
- 52 Week Low
- MGM $31.61
- ROIV $9.69
- 52 Week High
- MGM $48.25
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- MGM 37.71
- ROIV 44.16
- Support Level
- MGM $31.61
- ROIV $10.89
- Resistance Level
- MGM $34.05
- ROIV $11.26
- Average True Range (ATR)
- MGM 0.87
- ROIV 0.36
- MACD
- MGM 0.04
- ROIV -0.05
- Stochastic Oscillator
- MGM 34.56
- ROIV 41.01
About MGM MGM Resorts International
MGM Resorts is the largest resort operator on the Las Vegas Strip with 35,000 guest rooms and suites, representing about one fourth of all units in the market. The company's Vegas properties include MGM Grand, Mandalay Bay, Park MGM, Luxor, New York-New York, and Bellagio. The Strip contributed approximately 62% of total EBITDAR in 2023. MGM also owns US regional assets, which represented a low 20s share of 2023 EBITDAR (MGM's Macao EBITDAR was 17% of the total in 2023). MGM's US sports and i-gaming operations are currently a high-single-digit percentage of its total revenue. The company also operates the 56%-owned MGM China casinos with a new property that opened on the Cotai Strip in early 2018. We estimate MGM will open a resort in Japan in 2030.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.